Terms: = Cervical cancer AND TP53, TRP53, 7157, ENSG00000141510, P04637, LFS1, P53
2306 results:
1. The Role of SARS-CoV-2 Spike Protein in the Growth of cervical cancer Cells.
Willson CM; Lequio M; Zhu Z; Wakefield MR; Bai Q; Fajardo E; Xiao H; Leung S; Fang Y
Anticancer Res; 2024 May; 44(5):1807-1815. PubMed ID: 38677738
[TBL] [Abstract] [Full Text] [Related]
2. Structural insights into the functional mechanism of the ubiquitin ligase E6AP.
Wang Z; Fan F; Li Z; Ye F; Wang Q; Gao R; Qiu J; Lv Y; Lin M; Xu W; Luo C; Yu X
Nat Commun; 2024 Apr; 15(1):3531. PubMed ID: 38670961
[TBL] [Abstract] [Full Text] [Related]
3. Probing the Effects of Retinoblastoma Binding Protein 6 (RBBP6) Knockdown on the Sensitivity of Cisplatin in cervical cancer Cells.
Mehta H; Ambele MA; Mokgautsi N; Moela P
Cells; 2024 Apr; 13(8):. PubMed ID: 38667315
[TBL] [Abstract] [Full Text] [Related]
4. Deciphering age-specific molecular features in cervical cancer and constructing an angio-immune prognostic model.
Zhao X; Fan X; Lin X; Guo B; Yu Y
Medicine (Baltimore); 2024 Apr; 103(15):e37717. PubMed ID: 38608077
[TBL] [Abstract] [Full Text] [Related]
5. HPLC-ESI/MS-MS metabolic profiling of white pitaya fruit and cytotoxic potential against cervical cancer: Comparative studies, synergistic effects, and molecular mechanistic approaches.
El-Nashar HAS; Al-Azzawi MA; Al-Kazzaz HH; Alghanimi YK; Kocaebli SM; Alhmammi M; Asad A; Salam T; El-Shazly M; Ali MAM
J Pharm Biomed Anal; 2024 Jul; 244():116121. PubMed ID: 38581932
[TBL] [Abstract] [Full Text] [Related]
6. PAD-mediated citrullination is a novel candidate diagnostic marker and druggable target for HPV-associated cervical cancer.
Albano C; Biolatti M; Mazibrada J; Pasquero S; Gugliesi F; Lo Cigno I; Calati F; Bajetto G; Riva G; Griffante G; Landolfo S; Gariglio M; De Andrea M; Dell'Oste V
Front Cell Infect Microbiol; 2024; 14():1359367. PubMed ID: 38529474
[TBL] [Abstract] [Full Text] [Related]
7. Downregulation of LAMB3 Altered the Carcinogenic Properties of Human Papillomavirus 16-Positive cervical cancer Cells.
Wattanathavorn W; Seki M; Suzuki Y; Buranapraditkun S; Kitkumthorn N; Sasivimolrattana T; Bhattarakosol P; Chaiwongkot A
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473784
[TBL] [Abstract] [Full Text] [Related]
8. Integrated analysis of long non-coding RNAs and mRNAs associated with condyloma acuminatum.
Tao S; Cao P; Jin M; Suo P; Chen Y; Li Y
J Dermatol; 2024 May; 51(5):671-683. PubMed ID: 38421728
[TBL] [Abstract] [Full Text] [Related]
9. Structure of the p53 degradation complex from HPV16.
Wang JCK; Baddock HT; Mafi A; Foe IT; Bratkowski M; Lin TY; Jensvold ZD; Preciado López M; Stokoe D; Eaton D; Hao Q; Nile AH
Nat Commun; 2024 Feb; 15(1):1842. PubMed ID: 38418456
[TBL] [Abstract] [Full Text] [Related]
10. Developing Folate-Conjugated miR-34a Therapeutic for Prostate cancer: Challenges and Promises.
Li WJ; Wang Y; Liu X; Wu S; Wang M; Turowski SG; Spernyak JA; Tracz A; Abdelaal AM; Sudarshan K; Puzanov I; Chatta G; Kasinski AL; Tang DG
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396800
[TBL] [Abstract] [Full Text] [Related]
11. LOC644656 promotes cisplatin resistance in cervical cancer by recruiting ZNF143 and activating the transcription of E6-AP.
Li M; Chen J; Zhang H; Zhang Y; Wang J; Shen Z; Chen Y; Hou W; Chi C
Cell Signal; 2024 May; 117():111115. PubMed ID: 38395183
[TBL] [Abstract] [Full Text] [Related]
12. Utility of UV Signature Mutations in the Diagnostic Assessment of Metastatic Head and Neck Carcinomas of Unknown Primary.
Furlan KC; Saeed-Vafa D; Mathew TM; Saller JJ; Tabbara SO; Boyle TA; Wenig BM; Hernandez-Prera JC
Head Neck Pathol; 2024 Feb; 18(1):11. PubMed ID: 38393464
[TBL] [Abstract] [Full Text] [Related]
13. Evaluation of the anti-cancer efficacy of lipid nanoparticles containing siRNA against HPV16 E6/E7 combined with cisplatin in a xenograft model of cervical cancer.
Kang SW; Kang OJ; Lee JY; Kim H; Jung H; Kim H; Lee SW; Kim YM; Choi EK
PLoS One; 2024; 19(2):e0298815. PubMed ID: 38363779
[TBL] [Abstract] [Full Text] [Related]
14. Temporal regulation of gene expression and pathways in chemotherapy-induced senescence in HeLa cervical cancer cell line.
Sucularli C; Şimay Demir YD; Özdemir A; Ark M
Biosystems; 2024 Mar; 237():105140. PubMed ID: 38336224
[TBL] [Abstract] [Full Text] [Related]
15. Gold nanoparticles (AuNPs) decrease the viability of cervical cancer cells by inducing the BAX gene and activating antioxidant enzymes.
Kamil Shareef NA; Zandsalimi F; Tavoosidana G
Mol Biol Rep; 2024 Feb; 51(1):287. PubMed ID: 38329621
[TBL] [Abstract] [Full Text] [Related]
16. Exploring a novel seven-gene marker and mitochondrial gene TMEM38A for predicting cervical cancer radiotherapy sensitivity using machine learning algorithms.
Wang J; Mou X; Lu H; Jiang H; Xian Y; Wei X; Huang Z; Tang S; Cen H; Dong M; Liang Y; Shi G
Front Endocrinol (Lausanne); 2023; 14():1302074. PubMed ID: 38327905
[TBL] [Abstract] [Full Text] [Related]
17. METTL3-mediated HSPA9 m6A modification promotes malignant transformation and inhibits cellular senescence by regulating exosomal mortalin protein in cervical cancer.
Ao K; Yin M; Lyu X; Xiao Y; Chen X; Zhong S; Wen X; Yuan J; Ye M; Zhang J; Li X; Hao Y; Guo X
Cancer Lett; 2024 Apr; 587():216658. PubMed ID: 38253218
[TBL] [Abstract] [Full Text] [Related]
18. Predictive and prognostic biomarkers in female genital tract tumours: an update highlighting their clinical relevance and practical issues.
Wong RW; Cheung ANY
Pathology; 2024 Mar; 56(2):214-227. PubMed ID: 38212229
[TBL] [Abstract] [Full Text] [Related]
19. Immunohistopathological Study of Papillary Squamotransitional Carcinoma of Uterine Cervix.
Dhande B; Khandeparkar SGS; Gogate BP; Joshi AR; Gosavi SS; Mishra PV
Gulf J Oncolog; 2024 Jan; 1(44):16-24. PubMed ID: 38205568
[TBL] [Abstract] [Full Text] [Related]
20. Selenium promotes immunogenic radiotherapy against cervical cancer metastasis through evoking p53 activation.
Xu Y; Lai H; Pan S; Pan L; Liu T; Yang Z; Chen T; Zhu X
Biomaterials; 2024 Mar; 305():122452. PubMed ID: 38154440
[TBL] [Abstract] [Full Text] [Related]
[Next]